Atrophic Gastritis: A Related Factor for Osteoporosis in Elderly Women by Kim, Hye Won et al.
 
Atrophic Gastritis: A Related Factor for Osteoporosis in Elderly
Women
 
 
(Article begins on next page)
The Harvard community has made this article openly available.
Please share how this access benefits you. Your story matters.
Citation Kim, Hye Won, Yang-Hyun Kim, Kyungdo Han, Ga Eun Nam,
Gwang Seon Kim, Byoung-Duck Han, Anna Lee, Ji Yong Ahn,
and Byung Joon Ko. 2014. “Atrophic Gastritis: A Related Factor
for Osteoporosis in Elderly Women.” PLoS ONE 9 (7): e101852.
doi:10.1371/journal.pone.0101852.
http://dx.doi.org/10.1371/journal.pone.0101852.
Published Version doi:10.1371/journal.pone.0101852
Accessed February 16, 2015 3:58:25 PM EST
Citable Link http://nrs.harvard.edu/urn-3:HUL.InstRepos:12717489
Terms of Use This article was downloaded from Harvard University's DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at
http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAAAtrophic Gastritis: A Related Factor for Osteoporosis in
Elderly Women
Hye Won Kim
1., Yang-Hyun Kim
1., Kyungdo Han
2, Ga Eun Nam
1, Gwang Seon Kim
1, Byoung-Duck Han
1,
Anna Lee
3, Ji Yong Ahn
4*
", Byung Joon Ko
1,5*
"
1Department of Family Medicine, College of Medicine, Korea University, Seoul, Korea, 2Department of Biostatistics, College of Medicine, Catholic University, Seoul, Korea,
3Department of East Asian Languages, College of Language, Linguistic, and Literature, University of Hawaii at Manoa, Honolulu, Hawaii, United States of America,
4Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, 5Division of Endocrinology, Diabetes, and Metabolism,
Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, United States of America
Abstract
Purpose: Osteoporosis poses a great threat to the aging society. Hypochlorhydric or achlorhydric conditions are risk factors
for osteoporosis. Atrophic gastritis also decreases gastric acid production; however, the role of atrophic gastritis as a related
factor for osteoporosis is unclear. We investigated the relationship between atrophic gastritis and osteoporosis in
postmenopausal women over 60 years of age.
Subjects and Methods: A total of 401 postmenopausal women were included in this cross-sectional study, which was
conducted during their medical check-ups. Bone mineral densitometry was measured using a dual energy X-ray
absorptiometry. Atrophic gastritis was defined endoscopically if gastric mucosa in the antrum and the body were found to
be atrophied and thinned and submucosal vessels could be well visualized.
Results: The proportion of people with atrophic gastritis was higher in the osteoporotic group than in the group without
osteoporosis. A linear relationship was observed in the proportion of atrophic gastritis according to the categories of
normal, osteopenia, and osteoporosis at the lumbar spine (p for trend=0.039) and femur (p for trend=0.001). A multiple
logistic regression analysis revealed that the presence of atrophic gastritis was associated with an increased odds of
osteoporosis after adjusting for age, body mass index, triglyceride, high-density lipoprotein cholesterol, alcohol
consumption, and smoking status (odds ratio 1.89, 95% confidence interval 1.15–3.11).
Conclusions: Atrophic gastritis is associated with an increased likelihood of osteoporosis in Korean elderly women.
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Introduction
Osteoporosis is a metabolic bone disease characterized by the
decrease in bone mass with microarchitectual disruption and
enhanced skeletal fragility, resulting in an increase for fracture risk
[1]. Osteoporotic fractures cause disability and a substantial
burden to the society due to both loss of labor and increases in
medical expenses. An estimated nine million osteoporotic fractures
occurred worldwide in 2000; of these, 1.6 million were hip
fractures, 1.7 million occurred in the forearm, and 1.4 million
were vertebral fractures [2]. Fragility fractures accounted for
0.83% of the global burden associated with noncommunicable
diseases. Osteoporotic fractures contributed to more disability-
adjusted life years lost than the common cancers, except for lung
cancer, in Europe [2].
The incidences of osteoporosis and osteoporotic fractures are
greater in women than in men [3], and bone mineral density
decreases according to age [4]. The other risk factors for
osteoporosis include cigarette smoking [5], excessive alcohol
consumption [6], vitamin D deficiency [7], and low dietary
calcium [8]. Calcium is ionized in acidic conditions and absorbed
in the small bowel. Therefore, in either hypochlorhydric or
achlorhydric stomachs, calcium absorption is impaired [9].
Conditions causing a decrease in gastric acid secretion status,
including gastric surgery, and use of proton pump inhibitors
increase the risk for low bone mass or fractures [10,11]. Atrophic
gastritis, another hypochlorhydric condition, can adversely affect
bone mineral density; however, studies about atrophic gastritis and
bone mineral density are sparse and inconclusive [12,13].
PLOS ONE | www.plosone.org 1 July 2014 | Volume 9 | Issue 7 | e101852Moreover, to the best of our knowledge, no study has evaluated
this association in the elderly over 60 years of age.
The aim of this study was to investigate the relationship between
atrophic gastritis and osteoporosis in postmenopausal women aged
60 or older.
Materials and Methods
Study subjects
Participants in this study had undergone routine health check-
ups at the Center for Health Promotion in the Korea University
Anam Hospital located in Seoul, Korea between March 1, 2007
and March 31, 2009. A total of 12,593 persons were examined
during this period. Men (n=6801), persons below 60 years of age
(n=4783), pre- or peri-menopausal women or those with
unknown menopausal status (n=238), persons who had taken
drugs that can affect bone mineral density such as glucocorticoids,
estrogen, calcium, vitamin D, or bisphosphonates (n=197),
persons who were not examined with dual energy X-ray
absorptiometry (n=137), persons who were not examined with
esophagogastroduodenoscopy (n=30), those with history of gastric
surgery (n=2), and those whose endoscopic biopsy result was
dysplasia (n=4) were excluded from this study. The final study
sample had a total of 401 postmenopausal women aged 60 or
older. All participants signed the consent form and the Institu-
tional Review Board at the Korea University Anam Hospital
approved this study (IRB No. AN09141-001).
Anthropometric and laboratory measurements
All participants wore light clothing without shoes during
anthropometric measurement. Height and weight were estimated
to the nearest 0.1 cm and 0.1 kg, respectively. Body mass index
(BMI) was calculated using the following equation: weight (kg)
divided by the square of height (m). Blood pressure was measured
on the upper arm after 10 min of rest using an automated blood
pressure monitoring device (MP800, MEKICS, Chuncheon,
Korea).
Blood samples were obtained after overnight fasting for 10 h
between 08:00 h and 09:00 h. An automated analyzer (TB200FR;
Toshiba Co., Otawara, Japan) was used to analyze serum total
cholesterol (TC), triglycerides (TG), low-density lipoprotein
cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-
C), fasting blood glucose (FBG), and uric acid concentration.
Hemoglobin level was measured using flow cytometry (XE2100;
Sysmax, Kobe, Japan).
Endoscopic examination and histologic assessment
Biennial gastric cancer screening has been recommended for
individuals 40 years and older because of the high prevalence of
gastric cancer in Korea, with either an upper gastrointestinal series
or endoscopy [14]. Standardized esophagogastroduodenoscopy
(GIF-H260, Olympus Co., Tokyo, Japan) was performed by one of
two experienced endoscopists at Korea University Anam Hospital,
each of whom had at least 5 years of endoscopic experience with
over 10,000 cases. Endoscopic findings were described by the
overall impression regarding the presence of gastritis in the antrum
and the body of the stomach. Atrophic gastritis was defined
endoscopically if gastric mucosa in the antrum and the body were
atrophied and thinned and submucosal vessels could be well
visualized. A single highly experienced endoscopist (JYA) reviewed
all endoscopic images, and the diagnosis was confirmed after
careful evaluation. A single pathologist (CHK), who was unaware
of the clinical details, completed the histologic assessment. The
presence of Helicobacter pylori was assessed by hematoxylin and
eosin and cresyl-violet staining based on the Updated Sydney
System [15]. Only a subset of participants (n=130) underwent H.
pylori testing.
Bone mineral density
Bone mineral density (BMD) (g/cm
2) of central skeletal sites
(lumbar spine, total hip, and femoral neck) was evaluated using
dual energy X-ray absorptiometry (Discovery-W, Hologic, Bed-
ford, MA, USA). Lumbar spine BMD was measured using the
average value for L1 to L4. Femur BMD was chosen as the lowest
value between total hip and femoral neck BMD. Osteopenia or
osteoporosis was diagnosed using World Health Organization
criteria (–2.5,T-score,–1.0 or T-score#–2.5).
Statistical analysis
SPSS version 12.0 (SPSS Inc., Chicago, IL, USA) was used for
statistical analysis. Results are presented as means 6 standard
deviation, median with interquartile range, or frequencies and
percentages. p,0.05 was considered to be statistically significant.
Student t-tests, Mann-Whitney U test, chi-square tests, or Fisher’s
exact tests were used to compare the anthropometric, laboratory,
social, and endoscopic differences according to the presence of
osteoporosis. The chi-square test was used to compare the
proportion of atrophic gastritis according to three groups of
BMD at the lumbar spine and femur and the linear trend was
calculated by using the linear-by-linear association. A multiple
logistic regression analysis was performed to assess the association
between atrophic gastritis and osteoporosis. Variables that had
significant association (p,0.05) with the dependent variable
(osteoporosis) in univariate analysis or known risk factors for both
osteoporosis and atrophic gastritis were included in the model as
covariates. Initially, the analysis was performed without adjust-
ment. Then, age and BMI were adjusted in model 2. In model 3,
age, BMI, TG, and HDL-C were adjusted. Lastly, in addition to
the covariates in model 3, alcohol consumption and smoking status
were adjusted in model 4.
Results
The clinical and biochemical characteristics of the study
subjects are presented in Table 1. Osteoporotic patients were
older (66.0 versus 63.0 years), had lower BMI values (23.4 versus
24.5 kg/m
2), higher TG (129.5 versus 121.0 mg/dL), and lower
HDL-C levels (50.0 versus 52.0 mg/dL) than subjects without
osteoporosis. The proportion of people with atrophic gastritis was
higher (56.9 versus 43.1%) in the osteoporotic group than in the
group without osteoporosis. The percentage of H. pylori infections
was greater in the osteoporosis group than in the non-osteoporotic
group; however, the difference was not significant. Figure 1
describes the trend of an increasing percentage of atrophic gastritis
in the 3 groups of BMD. A linear relationship was observed in the
proportion of atrophic gastritis according to the categories of
normal, osteopenia, and osteoporosis at the lumbar spine (p for
trend=0.039) and femur (p for trend=0.001). A multiple logistic
regression analysis demonstrated that subjects with atrophic
gastritis had an increased likelihood of osteoporosis even after
adjusting for age, BMI, TG, HDL-C, alcohol consumption, and
smoking (model 4, OR 3.10, 95% CI 1.44–6.68) at the femur
(Table 2). A similar result was observed after adjustment was made
for anthropometric, laboratory, and social parameters when the
dependent variable was regarded as the presence of osteoporosis at
the lumbar spine or femur (model 4, OR 1.89, 95% CI 1.15–3.11).
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Atrophic gastritis increased the likelihood of osteoporosis in
postmenopausal women over 60 years of age. The association
remained significant even after controlling for anthropometric,
laboratory, and social variables. To the best of our knowledge, this
is the first report that evaluates the relationship between atrophic
gastritis and osteoporosis in the elderly over 60 years of age.
Osteoporosis poses a great threat to the aging society. Aging is
accompanied by the risk of osteoporosis and associated fractures,
thereby causing increased disability-adjusted life years lost
worldwide [2]. Aside from aging, osteoporosis and osteoporotic
fractures have many other risk factors. Females are at high risk for
osteoporosis. The peak bone mass of women was lower than that
of men, and the BMD levels of postmenopausal women decrease
abruptly after menopause because of a lack of estrogen [16,17].
Table 1. Clinical and biochemical characteristics of the study subjects.
Osteoporosis P value
a
Yes (n=102) No (n=299)
Age (yr) 66.0 (62.0–70.0) 63.0 (61.0–67.0) ,0.001
b
BMI (kg/m
2)
c 23.4 (22.2–25.0) 24.5 (22.6–26.2) ,0.001
SBP (mmHg) 126.7614.7 123.8613.7 0.075
DBP (mmHg) 70.9610.3 69.3610.2 0.169
Hemoglobin (g/dL) 13.361.1 13.361.1 0.738
TC (mg/dL) 191.3637.1 191.4632.5 0.776
TG (mg/dL)
c 129.5 (93.5–198.3) 121.0 (89.0–168.0) 0.028
HDL-C (mg/dL)
c 50.0 (42.0–59.0) 52.0 (44.0–61.0) 0.018
LDL-C (mg/dL)
c 118.0 (100.5–138.3) 115.0 (96.0–138.0) 0.732
FBG (mg/dL)
c 93.0 (87.8–101.0) 92.0 (86.0–100.0) 0.148
Uric acid (mg/dL)
c 4.4 (3.9–5.1) 4.5 (3.9–5.2) 0.434
Alcohol drinker 9 (8.9) 30 (10.2) 0.707
Current smoker 3 (3.0) 11 (3.7) 1.000
Atrophic gastritis 58 (56.9) 129 (43.1) 0.016
H. pylori infection
d 26 (61.9) 45 (51.1) 0.249
All values are means 6 SD for continuous parametric variables, median (interquartile range) for continuous nonparametric variables, or n (%) for categorical variables.
Osteoporosis was defined as a T-score#–2.5 at the lumbar spine or femur. BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; TC, total
cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; FBG, fasting blood glucose.
aCalculated by t-test, chi-square test, or Fisher’s exact test.
bCalculated by Mann-Whitney U test.
cLog-transformed before analysis.
dn=130.
doi:10.1371/journal.pone.0101852.t001
Figure 1. Proportion of atrophic gastritis in three groups of BMD at the lumbar spine and femur. BMD, bone mineral density.
doi:10.1371/journal.pone.0101852.g001
Atrophic Gastritis: A Related Factor for Osteoporosis in Elderly Women
PLOS ONE | www.plosone.org 3 July 2014 | Volume 9 | Issue 7 | e101852Cigarette smoking increases postmenopausal bone loss [5], and
heavy alcohol drinking exerts a negative effect on bone health [6].
Bone serves as a reservoir for the storage of calcium, and vitamin
D plays a critical role in gastrointestinal calcium absorption.
Therefore, vitamin D deficiency [7] and low dietary calcium [8]
facilitate bone loss and osteoporotic fractures.
Along with other risk factors for osteoporosis, hypochlorhydric
or achlorhydric conditions, including gastrectomy, and the use of
antacids are important because the dissolution and absorption of
calcium salts decrease in non-acidic conditions [9,11,18]. Stomach
resection adversely affected bone metabolism and decreased BMD
even in a partial gastrectomy group [19]. Gastrectomy, including
bariatric surgery, increases the risk of osteoporosis and fractures
due to weight loss and change of body composition as well as
calcium malabsorption [10,18]. In rats subjected to gastrectomy
and fundectomy, blood calcium concentration decreased slightly
within three weeks after surgery, reflecting an impaired capacity of
converting insoluble calcium into soluble calcium salts [20]. Acid-
suppressive medication use could also raise the risk of fractures. A
meta-analysis revealed that proton-pump inhibitors increase the
risk of hip, spine, and any-site fractures by 30, 56, and 16%,
respectively [11]. Long-term use of proton-pump inhibitors
markedly increased the risk of hip fractures in another study [21].
Atrophic gastritis, which is more prevalent in the elderly and
associated with H. pylori infection [22], is characterized by the loss
of an appropriate number of glands in the gastric mucosa [23] and
therefore causes a hypochlorhydric or achlorhydric stomach. As a
result, the absorption of minerals and vitamins could be
hampered; however, the relationship between the presence of
atrophic gastritis and micronutrient absorption has been poorly
studied [9]. Moreover, studies about atrophic gastritis and
osteoporosis are rare and inconclusive [12,13]. We found that
atrophic gastritis is associated with osteoporosis in postmenopausal
women aged 60 or older after adjusting for age, BMI, TG, HDL-
C, alcohol consumption, and smoking status. Previous studies
reported that there was no relationship between BMD and
atrophic gastritis [13,24]; however, the participants in these studies
were relatively young women below the age of 60. Aging is related
to the presence and the progression of atrophic gastritis and
intestinal metaplasia [22,25]. In a Korean study, the prevalence of
atrophic gastritis was more than 50% in antrum and 23.5% in
body for those older than 60 [22], which was in accordance with
our result (56.9% and 43.1% respectively in osteoporotic and non-
osteoporotic participants, Table 1). One of the possible reasons
that no relationship between BMD and atrophic gastritis was seen
in these studies is that the ability to produce acid in relatively
young participants remained, and moderate concentrations of acid
secretion would be enough to induce reasonable calcium absorption
in the small intestine. In addition, the study sample of these studies
had a heterogeneous nature, including different ethnicities [24], and
the sample sizes in these studies were small. The present study had a
larger sample size and only included women over 60 years of age of
a single population (native Korean). In a study of pepsinogen I and
BMD, decreased lumbar spine BMD correlated with a lower serum
level of group 1 pepsinogens [12]. The concentration of pepsinogen
I indicates the functional ability of the oxyntic mucosa, and thereby,
a decreased pepsinogen I level is a marker of mucosal atrophy [26].
This result is in agreement with our results, supporting the
hypothesis that the grade of atrophy in the oxyntic mucosa is
linearly correlated with the BMD.
Our report had several strengths, including its relatively large
sample size, and that it was drawn from a homogenous population
of elderly women over 60 years of age. However, this study also
had some weaknesses. First, the design of this study is cross-
sectional, not allowing for detection of causality. Second, the
diagnosis of atrophic gastritis was based on endoscopic findings,
not on biopsy specimens due to the nature of routine health check-
ups. In recent publications, however, a correlation was found
between endoscopic and histological findings in diagnosing
atrophic gastritis in Korean samples [27,28]. The young age
group (below 50 years) was associated with decreased sensitivity of
endoscopic diagnosis of atrophic gastritis in a study [28], which
infers that the sensitivity was fair in the elderly. We included only
women over 60 years of age in the study to avoid uncertainty in
the diagnosis of atrophic gastritis. Third, we only checked the
status of H. pylori infection from some participants due to the
nature of health examinations, and we did not assess the use of
drugs such as proton-pump inhibitors or antibiotics that can affect
biopsy results for H. pylori. Finally, we did not check the use of anti-
acid medications such as proton-pump inhibitors or histamine 2
blockers that can affect bone mineral density.
In conclusion, atrophic gastritis is associated with an increased
odds of osteoporosis in elderly women after adjusting for
anthropometric, laboratory, and social parameters. Further studies
are needed to identify our conclusions, which need to be
confirmed in studies with a prospective design, larger sample,
and other populations.
Supporting Information
Table S1 Data of atrophic gastritis, bone mineral
density, and other related variables.
(XLS)
Table 2. Relationship between atrophic gastritis and osteoporosis.
Lumbar spine Femur Lumbar spine or Femur
OR (95% CI) P value OR (95% CI) P value OR (95% CI) P value
Model 1
a 1.38 (0.86–2.22) 0.188 2.98 (1.43–6.21) 0.004 1.74 (1.10–2.74) 0.017
Model 2
b 1.31 (0.80–2.15) 0.278 2.93 (1.38–6.21) 0.005 1.70 (1.06–2.72) 0.027
Model 3
c 1.33 (0.80–2.21) 0.277 2.94 (1.38–6.27) 0.005 1.72 (1.06–2.78) 0.028
Model 4
d 1.45 (0.86–2.46) 0.164 3.10 (1.44–6.68) 0.004 1.89 (1.15–3.11) 0.012
Logistic regression analysis was performed. BMI, body mass index; HDL-C, high-density lipoprotein cholesterol; OR, odds ratio; CI, confidence interval.
aUnadjusted.
bAdjusted for age and BMI.
cAdjusted for all covariates in model 2 plus triglyceride and HDL-C.
dAdjusted for all covariates in model 3 plus alcohol consumption and smoking status.
doi:10.1371/journal.pone.0101852.t002
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